Methylation-specific PCR and pyrosequencing of the H19 ICR, H19 promotor and IGF2 DMR0 identified no differences in methylation between control and 3-M syndrome subjects, for both peripheral leucocyte and fibroblast-derived DNA. The gene discussed is IGF2; the disease is multiple congenital anomalies-hypotonia-seizures syndrome 3.